Regulatory Issues News Archive

What Does the Cigna-Express Scripts Merger Mean for the Future of Health Care?

What Does the Cigna-Express Scripts Merger Mean for the Future of Health Care?

The $67 billion merger between Cigna and Express Scripts will be the first of its kind.

Large Numbers of Negative Trial Results Impede Progress in Critical Care Medicine

Large Numbers of Negative Trial Results Impede Progress in Critical Care Medicine

Excessive numbers of negative clinical trials — many of which may be false-negative trials — are a major impediment to the advancement of critical care medicine.

Persistent Expenses Associated With High-Cost Medicare, Medicaid Beneficiaries

Persistent Expenses Associated With High-Cost Medicare, Medicaid Beneficiaries

Beneficiaries identified as "high cost" were likely to stay high cost over a 3 year period.

Without Medicaid Expansion, Poor Patients Forgo Medical Care

Without Medicaid Expansion, Poor Patients Forgo Medical Care

Doing without medical care is much more common among low-income residents of states that have not expanded Medicaid than among low-income people in other states.

FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers

FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers

The 23andMe Personal Genome Service Pharmacogenetic Reports test can detect 33 variants for multiple genes, corresponding to more than 50 commonly prescribed medications and over-the-counter products.

Reducing Race-Based Inequalities Across Health Care

Reducing Race-Based Inequalities Across Health Care

Data show that there is a significant difference in how black patients are treated compared with patients of other races.

Simplifying Medicare Plan Finder Improves Plan Selection

Simplifying Medicare Plan Finder Improves Plan Selection

Simplifying an internet-based decision support tool provided by the Centers for Medicare & Medicaid Services to help older adults make good plan choices in the Medicare prescription drug (Part D) program could result in selection of lower-cost plans.

Hospitals Charge 479% of Cost of Drugs on Average

Hospitals Charge 479% of Cost of Drugs on Average

On average, hospitals mark up drugs by 479 percent of their cost.

Medicaid Expansion Linked to Gains in Insurance Coverage

Medicaid Expansion Linked to Gains in Insurance Coverage

Medicaid expansion was associated with gains in insurance among low-income adults with substance use disorders, but corresponding treatment gains were not seen.

Drug Prices Increase More Than Expected After Shortages

Drug Prices Increase More Than Expected After Shortages

Prices for drugs under shortage increase more than twice as quickly as expected in the absence of a shortage.

FDA Announces Draft Guidance for Consumer OTC Access to Previously Prescription Drugs

FDA Announces Draft Guidance for Consumer OTC Access to Previously Prescription Drugs

The US Food and Drug Association has issued a draft guidance for helping prescription medications gain approval for nonprescription status.

Maryland Legislature: Will Federal Courts Permit State Regulation of Drug Prices?

Maryland Legislature: Will Federal Courts Permit State Regulation of Drug Prices?

In response to the growing burden of pharmaceutical products on state budgets, Maryland introduced House Bill 631 to prohibit manufacturer price gouging.

Aetna-CVS Merger Approved

Aetna-CVS Merger Approved

A $69 billion merger between health insurer Aetna and pharmacy manager CVS Health has been approved.

Manufacturers Increase Drug Prices Twice as Fast During Drug Shortages

Manufacturers Increase Drug Prices Twice as Fast During Drug Shortages

Prices of prescription drugs in short supply between 2015 and 2016 were found to increase more than twice as quickly as they would have in the absence of a shortage.

Generic Medications Offer Savings vs Brand-Name Combination Treatments

Generic Medications Offer Savings vs Brand-Name Combination Treatments

The difference in spending by Medicare on brand-name combination medications and the cost of the equivalent generic constituents was an estimated $925 million for 2016.

Trump to Sign Bills Lifting Drug Price 'Gag Orders' on Pharmacists

Trump to Sign Bills Lifting Drug Price 'Gag Orders' on Pharmacists

Two bills that allow U.S. pharmacists to disclose drug prices to customers to help them save money are expected to be signed today by President Donald Trump.

Strategies and Considerations for Improving Global Healthcare

Strategies and Considerations for Improving Global Healthcare

Although recent times have brought about significant technological and social advancements, the quality of healthcare worldwide continues to be inadequate.

FDA: Medtronic Update Addresses Cybersecurity Issue With CIED Programmers

FDA: Medtronic Update Addresses Cybersecurity Issue With CIED Programmers

The vulnerability is associated with using an internet connection to update software between the Medtronic CareLink and CareLink Encore Programmers (models 2090 and 29901) and the Medtronic Software Distribution Network (SDN).

The Open Access Debate: Should Patients Freely Access Research?

The Open Access Debate: Should Patients Freely Access Research?

Patients and their families are advocating for their right to access the latest medical research papers to help find potential treatments and understand health conditions.

Clinicians Raise Concerns About "Precision" Public Health in the Era of Genomics

Clinicians Raise Concerns About "Precision" Public Health in the Era of Genomics

Although the trend of "precision public health" promises to change the landscape of the public health field, concerns surrounding the scientific, practical, and ethical implications have cast a shadow over the innovation.

AMA Opposition to the CVS-Aetna Vertical Merger Grows With Statement to DOJ

AMA Opposition to the CVS-Aetna Vertical Merger Grows With Statement to DOJ

The American Medical Association has released a statement urging the US Department of Justice to block the CVS-Aetna merger.

Addressing Ethical Challenges Associated With Precision Medicine

Addressing Ethical Challenges Associated With Precision Medicine

There is a continual debate regarding which approaches should be used to base stratification of patients to precision therapy.

Bioethics Concerns Should Be a Key Element in mHealth Technology Development

Bioethics Concerns Should Be a Key Element in mHealth Technology Development

With the ubiquitous availability of digital technology such as smartphones, smart watches, health-related apps, and patient monitoring devices, the era of mHealth is upon us.

Addressing the Uncertainties of the Public Service Loan Forgiveness Program for Medical School Graduates

Addressing the Uncertainties of the Public Service Loan Forgiveness Program for Medical School Graduates

The Public Service Loan Forgiveness (PSLF) program promises to forgive any remaining federal loan debt for employees at governmental or nonprofit institutions following 10 years of loan repayments.

Ethical Concerns Arise in Clinical Trial Enrollment as Number of Uninsured and Underinsured Americans Skyrockets

Ethical Concerns Arise in Clinical Trial Enrollment as Number of Uninsured and Underinsured Americans Skyrockets

Until universal access to healthcare is ensured as a human right, researchers must keep important ethical concerns in mind when designing future clinical trials.

Medical Schools Phase Out Lectures as Education Shifts Outside the Classroom

Medical Schools Phase Out Lectures as Education Shifts Outside the Classroom

Medical students are choosing to forego lectures to use the time studying for the Step 1 exam instead.

AHA, ADA, and Others Express Concern Around Proposed Legislation to Protect Those With Preexisting Conditions

AHA, ADA, and Others Express Concern Around Proposed Legislation to Protect Those With Preexisting Conditions

The American Heart Association has published a statement in opposition of the latest Senate healthcare bill aimed at dismantling the Affordable Care Act.

Challenges Associated With Proposed Changes to CMS Fee Structure

Challenges Associated With Proposed Changes to CMS Fee Structure

A proposed restructuring of Centers for Medicare and Medicaid Services (CMS) Medicare Physician Fees may lead to an increase in required documentation and associated workload.

Cochrane Data Release and the Case for Open Science

Cochrane Data Release and the Case for Open Science

Cochrane's current policies allow only specific individuals with full library access to view and reuse data reports in their entirety.

Study Finds Clinical Trials for Newer, Breakthrough Therapies Lacking

Study Finds Clinical Trials for Newer, Breakthrough Therapies Lacking

More than half of the new approvals of Breakthrough Therapy drugs were based on a single pivotal trial.

AMA Code of Medical Ethics: Guidelines for End-of-Life Care

AMA Code of Medical Ethics: Guidelines for End-of-Life Care

Compassion and communication for both patients and families are among the most important factors involved in providing end-of-life care.

AMA Adopts Policy Promoting Health Equity As a Goal

AMA Adopts Policy Promoting Health Equity As a Goal

The American Medical Association House of Delegates has adopted a policy that sets health equity as a goal for the U.S. health care system.

FDA Seeks to Standardize Regulation of Mobile Medical Apps

FDA Seeks to Standardize Regulation of Mobile Medical Apps

Appropriate and standardized regulation of mobile medical applications may enable faster adoption and integration of these technology platforms in the health care environment

ACA Coverage Gains Include Workers Without Insurance

ACA Coverage Gains Include Workers Without Insurance

After ACA was implemented, self-employed individuals and wage earners without employer-sponsored health coverage offers had coverage gains equal to or greater than those of people not employed.

Should Brand-Name Drug Manufacturers Be Held Liable for Generic Drug Counterparts?

Should Brand-Name Drug Manufacturers Be Held Liable for Generic Drug Counterparts?

Both generic and brand manufacturers are protected from legal liability from failure-to-warn claims in most jurisdictions.

AMA Adopts Policy to Advance Gender Equity in Medicine

AMA Adopts Policy to Advance Gender Equity in Medicine

The American Medical Association (AMA) House of Delegates has adopted a new policy to study, act for, and advocate to advance gender equity in medicine.

Republican Opposition to Obamacare: What's Done, What's to Come

Republican Opposition to Obamacare: What's Done, What's to Come

Republicans who have fought against the Affordable Care Act (ACA) for years are at a crossroads after their opposition largely failed.

Steps Taken to Increase Use of Electronic Tools in Medicine

Steps Taken to Increase Use of Electronic Tools in Medicine

Additional codes have been approved by the Current Procedural Terminology Editorial Panel for chronic care remote physiologic monitoring and internet consultations.

FDA Approval of Medication With a Digital Monitoring System: Major Breakthrough or "Brave New World"?

FDA Approval of Medication With a Digital Monitoring System: Major Breakthrough or "Brave New World"?

Abilify MyCite adds a digital sensor to the medication aripiprazole. The sensor, an ingestible event marker, is activated by contact with stomach acids and transmits a signal to a skin patch the patient wears, which then transmits to an app.

AMA Proposes Policy Opposing Medicaid 'Lockout' Provisions

AMA Proposes Policy Opposing Medicaid 'Lockout' Provisions

A new policy opposing lockout provisions that block Medicaid patients from the program for lengthy periods and instead supporting allowing patients to reapply immediately for redetermination was adopted by the American Medical Association House of Delegates during the AMA's annual meeting in Chicago, according to an article published in the association's AMA Wire.

FDA Taps Social Media to Identify and Assess Emerging Drug Abuse Threats

FDA Taps Social Media to Identify and Assess Emerging Drug Abuse Threats

The FDA continues to battle the nation's opioid problem even as it looks to detect and prevent the next threat.

Marijuana's Uncertain Status: Closing the Gap Between State and Federal Policies

Marijuana's Uncertain Status: Closing the Gap Between State and Federal Policies

Senator Elizabeth Warren introduced a bipartisan bill in June 2018 (S.3032) that would exempt most marijuana-related activities from the Controlled Substances Act when they are allowed under state or tribal law.

New Short-Term Health Plans Have Large Coverage Gaps

New Short-Term Health Plans Have Large Coverage Gaps

There are large coverage gaps in short-term health plans that were approved Wednesday by the Trump administration.

The Halford Case Controversy: Are Institutional Review Board Regulations Too Strict?

The Halford Case Controversy: Are Institutional Review Board Regulations Too Strict?

William Halford, PhD, reportedly administered a live attenuated herpes simplex virus vaccine to 17 participants at an off-campus hotel without approval from an institutional review board.

Medical Cannabis Legalization Associated With Reduced Schedule III Opioid Prescriptions

Medical Cannabis Legalization Associated With Reduced Schedule III Opioid Prescriptions

In the United States, legalization of medical cannabis on a statewide basis was associated with a nearly 30% decrease in schedule III (but not schedule II) opioid prescription numbers and dosages for Medicaid patients.

Groups Urge CMS to Reconsider Suspending Risk Adjustment

Groups Urge CMS to Reconsider Suspending Risk Adjustment

Twenty-eight medical organizations, including AMA, sent letter to Administrator Verma of CMS

FDA Issues Complete Response Letter Rejecting Remoxy Approval

FDA Issues Complete Response Letter Rejecting Remoxy Approval

In June 2018, the FDA's Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee met and voted against (14-3) the approval of Remoxy upon data review.

The FDA Has the Authority to Explain Drug Application Rejections or Approvals. They Should Use It

The FDA Has the Authority to Explain Drug Application Rejections or Approvals. They Should Use It

The FDA has the ability within its governing laws to reveal to the public the reasons for its decisions to reject or approve drugs.

Better Care Quality Needed for Universal Health Coverage

Better Care Quality Needed for Universal Health Coverage

In order to achieve universal health coverage, stakeholders must focus on the quality of health services, including provision of effective, safe, timely, equitable, integrated, and efficient health services, according to a report published by the World Health Organization.

AMA Aims to Boost Affordability of ACA Marketplace Plans

AMA Aims to Boost Affordability of ACA Marketplace Plans

The American Medical Association House of Delegates has adopted policy to increase the number of people who obtain coverage through the Affordable Care Act by making marketplace plans more affordable.

Developing a New Set of Standards for Clinical Research Site Accreditation

Developing a New Set of Standards for Clinical Research Site Accreditation

Can groups with varying viewpoints come together to agree on a set of standards for the accreditation process?

Alternative Payment Models Should Include Precision Medicine

Alternative Payment Models Should Include Precision Medicine

The American Medical Association has committed to working to integrate precision medicine into alternative payment models.

Myriad Issues at Play in Expanding Access to Investigational Drugs for Unmet Medical Needs

Myriad Issues at Play in Expanding Access to Investigational Drugs for Unmet Medical Needs

Researchers evaluated the medical literature using terms including early access, compassionate use, pre-approval access, and named-patient programs.

As Immigration Policies Tighten, Physician Shortage Concerns Grow

As Immigration Policies Tighten, Physician Shortage Concerns Grow

The travel ban on citizens from several Middle Eastern countries has affected several faculty members and students, some of whom were in the process of completing courses or exams that would allow them to apply for residencies.

Trump White House Freezes Billions Earmarked for Insurers Through ACA

Trump White House Freezes Billions Earmarked for Insurers Through ACA

The White House announced earlier this month a plan to freeze billions of dollars of risk-adjustment payments scheduled to go to insurers through the Affordable Care Act.

Trials Supporting FDA Approval of Breakthrough Drugs Examined

Trials Supporting FDA Approval of Breakthrough Drugs Examined

Pivotal trials supporting U.S. Food and Drug Administration approvals granted Breakthrough Therapy designation often lack randomization, double-blinding, and control groups.

The Harmful Application of HIPAA: How to Protect Privacy and Patient Care

The Harmful Application of HIPAA: How to Protect Privacy and Patient Care

Despite good intentions, HIPAA is shrouded in myth and misapplication that does more harm than good for both patients and physicians.

CMS Physician Payment and Policy Changes Proposed for 2019

CMS Physician Payment and Policy Changes Proposed for 2019

CMS issued a proposal to update payment policies, quality provisions, and payment rates for services under the Medicare Physician Fee Schedule on or after January 1, 2019.

Government and Industry Lead the Way in Funding USPSTF Systematic Reviews

Government and Industry Lead the Way in Funding USPSTF Systematic Reviews

Researchers sought to assess the frequency of specific government agencies and organizations in their funding for the review studies.

International Group Develops Best Practices for Drug Packaging

International Group Develops Best Practices for Drug Packaging

Medical safety organizations and advocates from over 20 countries address the use of technologies to reduce errors and establish an international barcode standard for drug labeling and packaging.

New Rules May Constrain Docs' Ability to Treat Chronic Pain

New Rules May Constrain Docs' Ability to Treat Chronic Pain

New laws and regulations designed to limit the use of prescription narcotics may further constrain doctors' ability to treat patients.

FDA Outlines Plan for Increasing Nonprescription Drug Availability

FDA Outlines Plan for Increasing Nonprescription Drug Availability

The draft guidance, Innovative Approaches for Nonprescription Drug Products, applies to drugs under the New Drug Application (NDA) process and "is intended to extend that NDA pathway to include therapeutic indications that have not, historically, been available for use without a prescription," said Gottlieb in a press statement.

New Laws Are Needed to Protect Health Data Shared Online

New Laws Are Needed to Protect Health Data Shared Online

People often reveal detailed, sensitive data about their health via new technologies.

The Fight for Patient Privacy Under Big Data Analytics

The Fight for Patient Privacy Under Big Data Analytics

Introduced by the Trump administration in March 2018, the MyHealthEData initiative seeks to broaden patient access to electronic health records and insurance claims information.

Led by AG Sessions, DOJ Declines to Defend ACA Against Federal Lawsuit

Led by AG Sessions, DOJ Declines to Defend ACA Against Federal Lawsuit

California Attorney General Xavier Becerra pledged to lead the fight to protect the Affordable Care Act.

Growth in Healthcare Employment Has Led to Rise in Healthcare Costs

Growth in Healthcare Employment Has Led to Rise in Healthcare Costs

In an era in which technology constantly evolves and becomes smarter by the day, it's not surprising that healthcare costs continue to climb.

Medicaid Expansion Ups Access to Rehab in Young Adults With Injury

Medicaid Expansion Ups Access to Rehab in Young Adults With Injury

Utilizing the Healthcare Cost and Utilization Project State Inpatient Databases, changes in insurance coverage and risk adjusted outcomes among adults aged 19 to 44 years who were hospitalized for injuries before and after Medicaid expansion are explored.

Health System Expansions Place Patients at Risk for Safety Concerns

Health System Expansions Place Patients at Risk for Safety Concerns

System expansions in the current healthcare environment are making clear impacts on clinical care and patient safety.

ACP: Delay, Denial of H-1B Visas Disruptive to Training, Patient Care

ACP: Delay, Denial of H-1B Visas Disruptive to Training, Patient Care

The denial or delay of visas for international students is disruptive to both the training program and to patient care.

FDA: Draft Guidance for the Inclusion of Pregnant Women in Clinical Trials

FDA: Draft Guidance for the Inclusion of Pregnant Women in Clinical Trials

The US Food and Drug Administration (FDA) has issued draft guidance for industry regarding the science and ethics of including pregnant women in drug development clinical trials.

FDA Working to Mitigate Burden of Drug Shortages for Patients

FDA Working to Mitigate Burden of Drug Shortages for Patients

The US Food and Drug Administration has committed to reducing unexpected disruptions in the supply chain of drugs and medical supplies resulting in shortages.

ACP Outlines Steps to Improve Women's Healthcare Equity

ACP Outlines Steps to Improve Women's Healthcare Equity

The American College of Physicians has released 7 position statements supporting equality in healthcare for women.

Global Variation in Personal Health Care Access and Quality

Global Variation in Personal Health Care Access and Quality

Researchers used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 to examine personal health care access and quality with the Healthcare Access and Quality Index for 195 countries and territories, as well as subnational locations.

Congress Approves Bill Expanding Private Care for VA Patients

Congress Approves Bill Expanding Private Care for VA Patients

Patients served by the beleaguered Veterans Affairs health system may have wider access to private care, thanks to a bill approved Wednesday by the Senate.

CDC: No Change in Level of Uninsured in U.S. in 2017

CDC: No Change in Level of Uninsured in U.S. in 2017

Overall, 9.1 percent of individuals in the United States were uninsured in 2017, which was not significantly different from the level in 2016.

Nonprofit Manufacturer Could Keep Generic Drug Costs Down

Nonprofit Manufacturer Could Keep Generic Drug Costs Down

Researchers discuss generic drug market failure, whereby a generic drug manufacturer increases the drug price, which can compromise care.

White House Unveils Plan to Lower Cost of Prescription Drugs

White House Unveils Plan to Lower Cost of Prescription Drugs

FDA Commissioner, Scott Gottlieb MD, said, "The FDA shares the goal of ensuring that American patients have access to quality and affordable care that meets their needs."

Medical Marijuana Users More Likely to Use Prescription Drugs for Medical, Nonmedical Purposes

Medical Marijuana Users More Likely to Use Prescription Drugs for Medical, Nonmedical Purposes

Patients who use medical marijuana may be more likely to use prescription drugs for both medical and nonmedical purposes.

Making Alternative Payment Plans Mandatory: Inherent Risks and Pitfalls in Reducing Healthcare Costs

Making Alternative Payment Plans Mandatory: Inherent Risks and Pitfalls in Reducing Healthcare Costs

The Center for Medicare and Medicaid Innovation (CMMI) program was created by the Affordable Care Act to identify and test new strategies for reimbursement in an effort to reduce growing healthcare costs.

Regulatory Requirements Drive Dissatisfaction With EHRs

Regulatory Requirements Drive Dissatisfaction With EHRs

Regulatory requirements are likely to be an important aspect of physician dissatisfaction with electronic health records that is driving burnout.

Many Organizations Not Meeting Trial Reporting Requirements

Many Organizations Not Meeting Trial Reporting Requirements

Only 19 percent of organizations use computer software to monitor compliance with Final Rule.

Lyrica Approved as Adjunctive Tx for Partial Onset Seizures in Children

Lyrica Approved as Adjunctive Tx for Partial Onset Seizures in Children

The approval was based on a 12-week, double-blind, placebo-controlled study (N=295) in pediatric patients 4-17 years of age.

Medicine and Conscience Intersect at the Department of Health and Human Services

Medicine and Conscience Intersect at the Department of Health and Human Services

The Department of Health and Human Services has announced the creation of the Conscience and Religious Freedom Division within the HHS Office of Civil Rights.

Anesthesiologists Report Drug Shortages Affecting Patient Care

Anesthesiologists Report Drug Shortages Affecting Patient Care

Survey finds that 98 percent of respondents report experiencing drug shortages on a consistent basis.

Medicare Requiring Hospitals to Post Prices Online

Medicare Requiring Hospitals to Post Prices Online

U.S. hospitals will have to post their standard prices online and make it easier for patients to access their electronic medical records, Medicare officials said.

Scale of Online Marketplace for Marijuana Increasing

Scale of Online Marketplace for Marijuana Increasing

Researchers examined the scale and growth trajectory of the online marketplace for marijuana by analyzing aggregate internet searches and the links searchers typically found.

DOJ Rescinds Protections Afforded by Americans With Disabilities Act

DOJ Rescinds Protections Afforded by Americans With Disabilities Act

The Department of Justice, under the guidance of Attorney General Jeff Sessions, has withdrawn a number of protections afforded to people with disabilities under the Americans with Disabilities Act.

ACP: Position Paper Shares Top Principles of Volunteer Medical Experiences

ACP: Position Paper Shares Top Principles of Volunteer Medical Experiences

The position paper focuses on the 4 accepted principles of healthcare: beneficence, nonmaleficence, justice, and respect for autonomy.

Individual Consent for Health Research: Ethical Obligations vs Public Good

Individual Consent for Health Research: Ethical Obligations vs Public Good

A recent paper examines the circumstances in which public good outweighs the requirement that researchers receive individual consent to use a person's data.

Kratom-Containing Dietary Supplements Recalled

Kratom-Containing Dietary Supplements Recalled

The FDA said it wants all companies making kratom products to take them off the market, and urged all consumers who have kratom-containing products to stop using them and throw them away.

ACA Coverage Expansion Places Spending Burden on Low- to Middle-Income Households

ACA Coverage Expansion Places Spending Burden on Low- to Middle-Income Households

Although the Affordable Care Act's coverage expansions have reduced out-of-pocket spending for low- and middle-income individuals, these patients continue to experience a high burden of premium and out-of-pocket spending.

Evaluating the Consequences of the Federal Right-to-Try Legislation

Evaluating the Consequences of the Federal Right-to-Try Legislation

Federal "right-to-try" legislation will restrict the FDA's oversight of access to investigational drugs for patients with life-threatening illnesses and diminish the FDA's public health mission

Seven Potential Harmful Consequences of the CDC's Banned Words List

Seven Potential Harmful Consequences of the CDC's Banned Words List

Experts advise that should the CDC be banned from using certain words, it could give rise to at least 7 harmful consequences.

Congress Urged to Reverse CMS Policy That Could Affect Specialists, Patients

Congress Urged to Reverse CMS Policy That Could Affect Specialists, Patients

Many healthcare organizations are calling on Congress to reverse the new Centers for Medicare & Medicaid Services policy that has the potential to jeopardize patient access to Part B drug therapies.

FDA Accepts New Drug Application for Postoperative Ocular Pain, Inflammation

FDA Accepts New Drug Application for Postoperative Ocular Pain, Inflammation

The FDA has accepted a New Drug Application for an investigational topical twice-a-day product for the treatment of inflammation and pain in patients who have undergone ocular surgery.

Trump Administration Hands CDC a List of "Forbidden Words"

Trump Administration Hands CDC a List of "Forbidden Words"

Policy analysts at the Centers for Disease Control and Prevention have been informed to stop using certain terms in documents to be used in next year's budget.

AHA Voices Concerns Over Tax Reform Bill

AHA Voices Concerns Over Tax Reform Bill

After the Republicans passed their tax reform bill in the Senate over the weekend, the American Heart Association released a statement detailing their concerns about the legislation.

CMS Launches Initiative to Analyze Impact of Provider Regulations on Patient Care

CMS Launches Initiative to Analyze Impact of Provider Regulations on Patient Care

The Centers for Medicare & Medicaid Services has launched an initiative to examine which provider regulations should be discarded or revamped amid concerns that the regulations are reducing the amount of time that physicians spend with patients.

FDA Expresses Safety Concern Over Kratom

FDA Expresses Safety Concern Over Kratom

The Food and Drug Administration's Commissioner Scott Gottlieb, MD, has issued a statement regarding the deadly risks associated with the botanical substance, kratom.

Medical Schools' Social Mission Critical for Societal Health Equity

Medical Schools' Social Mission Critical for Societal Health Equity

Enhancing health equity and addressing societal healthcare disparities is dependent on American medical schools committing to a social mission.

Sign Up for Free e-Newsletters